Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Target ID: TTDR01241

Target Information
NameTyrosine kinase    
Type of targetResearch target    
SynonymsPTK    
Protein-tyrosine kinase    
Tyrosine kinase    
DiseaseSolid tumors
[ICD9: 140-199, 210-229   ICD10: C00-C75, C7A, C7B, D10-D36, D3A]
[1]
EC NumberEC 2.7.1.112
Related US Patent6,239,133
6,245,759
6,306,874
6,313,138
6,344,455
6,350,754
6,355,636
6,420,382
6,479,512
6,489,328
6,498,176
6,506,769
6,518,316
6,541,504
6,544,988
6,548,496
6,559,173
6,562,818
6,579,897
6,586,423
6,586,424
6,596,746
6,602,863
6,608,048
6,630,489
6,653,308
6,656,940
6,747,025
InhibitorPKI166[2][1]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Tyrosine kinase inhibitors: from rational design to clinical trials. Med Res Rev. 2001 Nov;21(6):499-512. To Reference
Ref 2Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Exp Cell Res. 2009 Apr 15;315(7):1302-12. Epub 2009 Feb 12. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543